Royal Bank of Canada’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$32K Sell
5,158
-2,255
-30% -$14K ﹤0.01% 5719
2025
Q1
$36K Buy
7,413
+6,371
+611% +$30.9K ﹤0.01% 5306
2024
Q4
$10K Sell
1,042
-794
-43% -$7.62K ﹤0.01% 5848
2024
Q3
$15K Sell
1,836
-1,813
-50% -$14.8K ﹤0.01% 5732
2024
Q2
$24K Buy
3,649
+2,438
+201% +$16K ﹤0.01% 5595
2024
Q1
$3K Sell
1,211
-23,795
-95% -$58.9K ﹤0.01% 6134
2023
Q4
$60K Sell
25,006
-52,781
-68% -$127K ﹤0.01% 5376
2023
Q3
$264K Sell
77,787
-37,568
-33% -$128K ﹤0.01% 4079
2023
Q2
$849K Buy
115,355
+91,904
+392% +$676K ﹤0.01% 3137
2023
Q1
$243K Buy
23,451
+3,250
+16% +$33.7K ﹤0.01% 4092
2022
Q4
$238K Buy
20,201
+17,847
+758% +$210K ﹤0.01% 4275
2022
Q3
$50K Buy
2,354
+638
+37% +$13.6K ﹤0.01% 5249
2022
Q2
$54K Sell
1,716
-3,126
-65% -$98.4K ﹤0.01% 5216
2022
Q1
$198K Sell
4,842
-12,785
-73% -$523K ﹤0.01% 4624
2021
Q4
$767K Sell
17,627
-379,190
-96% -$16.5M ﹤0.01% 3604
2021
Q3
$19.9M Buy
396,817
+38,291
+11% +$1.92M 0.01% 1184
2021
Q2
$22.6M Sell
358,526
-52,088
-13% -$3.28M 0.01% 1128
2021
Q1
$38.2M Buy
410,614
+151,941
+59% +$14.1M 0.01% 755
2020
Q4
$23.2M Sell
258,673
-12,369
-5% -$1.11M 0.01% 1007
2020
Q3
$28M Sell
271,042
-96,639
-26% -$9.99M 0.01% 773
2020
Q2
$29.1M Sell
367,681
-37,563
-9% -$2.97M 0.01% 722
2020
Q1
$23.4M Buy
405,244
+7,344
+2% +$425K 0.01% 722
2019
Q4
$21.5M Sell
397,900
-42,553
-10% -$2.3M 0.01% 962
2019
Q3
$23M Sell
440,453
-39,451
-8% -$2.06M 0.01% 858
2019
Q2
$23.2M Sell
479,904
-120,608
-20% -$5.83M 0.01% 866
2019
Q1
$30.3M Sell
600,512
-43,761
-7% -$2.21M 0.01% 684
2018
Q4
$38.2M Sell
644,273
-303,588
-32% -$18M 0.02% 528
2018
Q3
$62.4M Sell
947,861
-111,059
-10% -$7.31M 0.03% 420
2018
Q2
$53.5M Sell
1,058,920
-112,395
-10% -$5.67M 0.02% 458
2018
Q1
$61.7M Sell
1,171,315
-76,314
-6% -$4.02M 0.03% 424
2017
Q4
$58M Buy
1,247,629
+124,698
+11% +$5.79M 0.03% 451
2017
Q3
$45.4M Buy
1,122,931
+164,363
+17% +$6.65M 0.02% 522
2017
Q2
$32.5M Buy
958,568
+19,833
+2% +$673K 0.02% 640
2017
Q1
$27.3M Buy
938,735
+174,891
+23% +$5.08M 0.01% 704
2016
Q4
$25.1M Buy
763,844
+398,795
+109% +$13.1M 0.01% 752
2016
Q3
$11.5M Buy
365,049
+349,319
+2,221% +$11M 0.01% 1149
2016
Q2
$442K Sell
15,730
-3,261
-17% -$91.6K ﹤0.01% 3171
2016
Q1
$690K Sell
18,991
-10,681
-36% -$388K ﹤0.01% 2826
2015
Q4
$1.19M Buy
29,672
+25,242
+570% +$1.01M ﹤0.01% 2429
2015
Q3
$127K Buy
4,430
+932
+27% +$26.7K ﹤0.01% 4043
2015
Q2
$116K Sell
3,498
-12,902
-79% -$428K ﹤0.01% 4251
2015
Q1
$472K Sell
16,400
-109
-0.7% -$3.14K ﹤0.01% 3134
2014
Q4
$449K Sell
16,509
-3
-0% -$82 ﹤0.01% 3149
2014
Q3
$352K Sell
16,512
-3,363
-17% -$71.7K ﹤0.01% 3273
2014
Q2
$447K Buy
19,875
+1,819
+10% +$40.9K ﹤0.01% 3060
2014
Q1
$456K Sell
18,056
-48,300
-73% -$1.22M ﹤0.01% 2961
2013
Q4
$1.53M Buy
66,356
+42,706
+181% +$982K ﹤0.01% 2039
2013
Q3
$451K Buy
23,650
+2,609
+12% +$49.8K ﹤0.01% 2954
2013
Q2
$303K Buy
+21,041
New +$303K ﹤0.01% 3040